| 1 |
35628225 | Impact of Atorvastatin on Skeletal Muscle Mitochondrial Activity, Locomotion and Axonal Excitability-Evidence from ApoE-/- Mice. | 2022 May 12 |
1 |
| 2 |
33050984 | Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease. | 2021 Mar |
1 |
| 3 |
34684024 | Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced Atherosclerosis. | 2021 Oct 19 |
1 |
| 4 |
34747636 | Endothelial Yin Yang 1 Phosphorylation at S118 Induces Atherosclerosis Under Flow. | 2021 Dec 3 |
1 |
| 5 |
32762716 | Atorvastatin promotes bone formation in aged apoE-/- mice through the Sirt1-Runx2 axis. | 2020 Aug 6 |
3 |
| 6 |
32967121 | Plasma APE1/Ref-1 Correlates with Atherosclerotic Inflammation in ApoE-/- Mice. | 2020 Sep 21 |
1 |
| 7 |
33210255 | Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE-/- mice. | 2020 Dec |
1 |
| 8 |
30551396 | Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice. | 2019 Jan |
1 |
| 9 |
29217477 | Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins. | 2018 Feb |
1 |
| 10 |
29556362 | Ultrasound Molecular Imaging of Atherosclerosis for Early Diagnosis and Therapeutic Evaluation through Leucocyte-like Multiple Targeted Microbubbles. | 2018 |
1 |
| 11 |
30344653 | Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice. | 2018 Nov |
1 |
| 12 |
26886754 | Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque. | 2017 Jan |
3 |
| 13 |
28369137 | Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. | 2017 |
1 |
| 14 |
28450907 | Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway. | 2017 Mar |
1 |
| 15 |
26956896 | Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice. | 2016 Apr |
1 |
| 16 |
27428373 | Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice. | 2016 |
1 |
| 17 |
27574007 | Atorvastatin attenuates p‑cresyl sulfate‑induced atherogenesis and plaque instability in ApoE knockout mice. | 2016 Oct |
2 |
| 18 |
25027757 | [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice]. | 2015 Jan-Feb |
3 |
| 19 |
26063978 | Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP. | 2015 |
1 |
| 20 |
26174316 | Protective activity ethanol extract of the fruits of Illicium verum against atherogenesis in apolipoprotein E knockout mice. | 2015 Jul 15 |
1 |
| 21 |
23625977 | Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis. | 2014 May |
1 |
| 22 |
24816562 | Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors. | 2014 |
1 |
| 23 |
25326709 | Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice. | 2014 Oct 18 |
1 |
| 24 |
23559030 | In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice. | 2013 Jul |
1 |
| 25 |
23615158 | Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice. | 2013 Aug |
2 |
| 26 |
22104174 | Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice. | 2012 |
2 |
| 27 |
21130458 | Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. | 2011 Feb |
2 |
| 28 |
21440631 | Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. | 2011 Jul |
1 |
| 29 |
22163030 | Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. | 2011 |
1 |
| 30 |
20538289 | Celecoxib combined with atorvastatin prevents progression of atherosclerosis. | 2010 Oct |
1 |
| 31 |
19556713 | Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice. | 2009 Jun |
1 |
| 32 |
19881226 | NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. | 2009 Nov |
2 |
| 33 |
18289605 | Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. | 2008 Mar 26 |
2 |
| 34 |
19088845 | Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation. | 2008 |
1 |
| 35 |
16305803 | MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis. | 2006 Mar 20 |
2 |
| 36 |
16741003 | Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin. | 2006 Jun |
1 |
| 37 |
16959191 | Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis. | 2006 |
2 |
| 38 |
17207421 | Endoglin expression in hyper-cholesterolemia and after atorvastatin treatment in apoE-deficient mice. | 2006 |
1 |